The first Co-Diagnostics trade was made in Q1 2018.
Since then Ken Griffin bought shares 40 more times and sold shares on 36 occasions. The investor completely sold their stake between Q1 2026 and Q1 2026.
Avg closing price
Price range
Sold -352 shares
Q4 2025
Avg closing price
$17.30
Price range
$0.32
-
$216.72
New holding (+352 shares)
Q3 2025
Avg closing price
$0.31
Price range
$0.25
-
$0.64
Sold -6.3k shares
Q2 2025
Avg closing price
$0.31
Price range
$0.23
-
$0.38
Increased shares by 1050.2% (+5.76k shares)
Q1 2025
Avg closing price
$0.64
Price range
$0.31
-
$1.00
Sold 35.2% shares (-298 shares)
Q4 2024
Avg closing price
$1.05
Price range
$0.70
-
$1.36
Sold 52.7% shares (-944 shares)
Q3 2024
Avg closing price
$1.28
Price range
$1.02
-
$1.75
Sold 26.3% shares (-638 shares)
Q2 2024
Avg closing price
$1.21
Price range
$1.01
-
$1.70
Sold 24.5% shares (-789 shares)
Q1 2024
Avg closing price
$1.21
Price range
$1.06
-
$1.42
Increased shares by 33.7% (+812 shares)
Q4 2023
Avg closing price
$1.18
Price range
$1.00
-
$1.50
Increased shares by 30.3% (+560 shares)
Q3 2023
Avg closing price
$1.26
Price range
$1.03
-
$1.85
Increased shares by 67.2% (+743 shares)
Q2 2023
Avg closing price
$1.28
Price range
$1.04
-
$1.64
Increased shares by 45.3% (+345 shares)
Q1 2023
Avg closing price
$2.67
Price range
$1.39
-
$3.24
New holding (+761 shares)
Q4 2022
Avg closing price
$3.12
Price range
$2.32
-
$3.68
Sold -4.09k shares
Q3 2022
Avg closing price
$4.66
Price range
$2.87
-
$7.01
Increased shares by 47.6% (+1.32k shares)
Q2 2022
Avg closing price
$5.07
Price range
$3.76
-
$6.29
Increased shares by 11.1% (+276 shares)
Q1 2022
Avg closing price
$6.90
Price range
$5.03
-
$9.61
Sold 38.0% shares (-1.53k shares)
Q4 2021
Avg closing price
$8.74
Price range
$8.12
-
$10.37
Sold 46.4% shares (-3.48k shares)
Q3 2021
Avg closing price
$9.73
Price range
$7.48
-
$11.38
Increased shares by 94.4% (+3.64k shares)
Q2 2021
Avg closing price
$8.57
Price range
$7.16
-
$9.56
Increased shares by 133.5% (+2.21k shares)
Q1 2021